Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Carcinoma, Ductal, Breast
  • Carcinoma, Lobular
  • Lymph Node Excision
  • Receptor, ErbB-2
  • Receptors, Estrogen
  • Receptors, Progesterone

abstract

  • On the basis of our findings and the lack of prospective randomized data, the practice of selectively limiting ALND to IHC-only patients thought to be at high risk and to patients for whom the identification of additional positive nodes may change systemic therapy recommendations seems to be a safe and reasonable approach.

publication date

  • April 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1245/s10434-009-0834-5

PubMed ID

  • 20033325

Additional Document Info

start page

  • 1063

end page

  • 8

volume

  • 17

number

  • 4